8-K: JELD-WEN Holding, Inc. Stockholders Approve Amended and Restated 2017 Omnibus Equity Plan
8-K Filing
JELD-WEN Holding, Inc. held its 2025 Annual Meeting of Stockholders on April 24, 2025, where stockholders approved the amended and restated 2017 Omnibus Equity Plan, increasing the available share reserve by 2 million shares.
Summary
- JELD-WEN Holding, Inc. held its Annual Meeting of Stockholders on April 24, 2025.
- Stockholders approved the amended and restated 2017 Omnibus Equity Plan, increasing the available share reserve by 2 million shares.
- The Equity Plan was previously approved by the Board of Directors, subject to stockholder approval.
- At the Annual Meeting, 78,178,392 shares were voted in person or by proxy, representing approximately 91.58% of shares entitled to vote.
- Stockholders elected ten directors for a one-year term expiring at the 2026 Annual Meeting.
- An advisory vote to approve the compensation of named executive officers was approved.
- The appointment of PricewaterhouseCoopers LLP as independent auditor for 2025 was ratified.
Sentiment
Score: 7
Explanation: The document reflects a routine corporate event (annual meeting) with positive outcomes (approval of equity plan, election of directors). The sentiment is neutral to slightly positive.
Positives
- Stockholder approval of the amended and restated 2017 Omnibus Equity Plan allows the company to continue to attract, retain, incentivize and motivate officers and employees of, consultants to, and non-employee directors providing services to, the Company and its Subsidiaries and Affiliates.
- High voter turnout (91.58%) indicates strong stockholder engagement.
Future Outlook
The amended Equity Plan is designed to incentivize and motivate employees, consultants, and directors, aligning their interests with those of the stockholders and promoting the company's success.
Industry Context
Equity compensation plans are a common tool used by publicly traded companies to attract and retain talent, aligning employee incentives with shareholder value.
Comparison to Industry Standards
- The structure of JELD-WEN's equity plan, including the types of awards (options, restricted stock, performance awards), is consistent with industry standards.
- The individual participant limits and vesting schedules are also generally in line with what is observed at comparable companies.
- Companies like Masonite International and Fortune Brands Innovations also utilize similar equity compensation plans.
Stakeholder Impact
- The approval of the Equity Plan benefits employees, consultants, and directors by providing them with a proprietary interest in the company's performance.
- Shareholders benefit from the alignment of employee incentives with shareholder value.
- The ratification of the independent auditor ensures the integrity of the company's financial reporting.
Key Dates
| Date | Description |
|---|---|
| January 3, 2017 | The 2017 Omnibus Equity Plan was originally adopted by the Board of Directors |
| January 20, 2017 | The 2017 Omnibus Equity Plan was approved by the Company's stockholders |
| February 23, 2021 | The 2017 Omnibus Equity Plan was amended and restated by the Compensation Committee |
| February 16, 2022 | The 2017 Omnibus Equity Plan was amended and restated by the Board of Directors |
| April 28, 2022 | The 2017 Omnibus Equity Plan was approved by the Company's stockholders |
| March 13, 2025 | Date of the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission |
| February 5, 2025 | The 2017 Omnibus Equity Plan was amended and restated by the Compensation Committee |
| February 5, 2025 | The 2017 Omnibus Equity Plan was amended and restated by the Board of Directors |
| April 24, 2025 | Date of the 2025 Annual Meeting of Stockholders and approval of the amended and restated Equity Plan. |
| April 25, 2025 | Date of the 8-K filing. |
Keywords
Equity Plan, Annual Meeting, Stockholders, Directors, JELD-WEN, Shares, Voting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.